Inicio・Lista de Acciones・Erasca Inc

Erasca Inc

Cerrado

16.43 2.11

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

Máximo

16.22

Métricas clave
By Trading Economics
Ingresos	139M -44M
BPA	-0.14
Empleados	103
EBITDA	139M -43M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+49.04% upside

Dividendos
By Acuity
Próximas Ganancias	10 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-36M 6.3B
Apertura anterior	14.32
Cierre anterior	16.43

Erasca Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 sept 2026, 23:51 UTC

Australia's Consumer Confidence Index set for release amid mixed market sentiment and rising interest rate concerns.

7 sept 2026, 23:51 UTC

Australia's Westpac Consumer Confidence Index set for release on September 8, amid cautious optimism in the stock market despite global economic uncertainties.

7 sept 2026, 23:51 UTC

UK Retail Sales Growth Slows to 0.5% YoY, Falling Short of Expectations Amid Consumer Caution

7 sept 2026, 23:51 UTC

U.S. Initial Jobless Claims Expected at 205,000 Amid Strong Labor Market and Anticipated Fed Rate Hikes

7 sept 2026, 23:51 UTC

China's Producer Prices Index Expected to Rise 3.7% Amid Mixed Economic Signals Ahead of September Release

7 sept 2026, 23:41 UTC

Japan's Q2 2026 GDP Growth Rate Expected at 0.4% Amid Optimistic Economic Sentiment and Rising Nikkei Index

7 sept 2026, 23:41 UTC

Japan's Q2 2026 GDP Growth Expected at +1.1% Amid Positive Economic Trends and Optimistic Market Sentiment

7 sept 2026, 23:41 UTC

Japan's Current Account Expected at JPY 2,870 Billion Amid Positive Economic Sentiment and Speculation of Interest Rate Hikes.

7 sept 2026, 23:31 UTC

ECB President Lagarde's Upcoming Speech Sparks Market Anticipation for Rate Hike Amid Rising Inflation and Geopolitical Tensions.

7 sept 2026, 23:21 UTC

U.S. Core Inflation Rate Expected to Rise to 2.4% YoY Amid Strong Jobs Data, Heightening Speculation on Fed Interest Rate Hikes

7 sept 2026, 23:21 UTC

Core Inflation Rate Release on September 11, 2026, Expected to Influence Fed's Interest Rate Decisions Amid Rising Geopolitical Tensions and Oil Prices.

7 sept 2026, 23:21 UTC

Investors Brace for CPI Release Amid Rising Inflation Concerns and Fed Rate Hike Speculation on September 11, 2026.

7 sept 2026, 23:21 UTC

U.S. Inflation Rate Expected to Rise 0.4% in August Amid Concerns of Federal Reserve Interest Rate Hikes Following Strong Job Growth

7 sept 2026, 23:21 UTC

U.S. CPI Report on September 11, 2026 Expected to Show Inflation Rise Amid Market Caution and Fed Rate Hike Speculation

7 sept 2026, 23:21 UTC

U.S. Inflation Rate Expected to Rise 3.4% YoY, Heightening Fed Rate Hike Speculations Amid Geopolitical Tensions and Oil Price Surge

7 sept 2026, 23:11 UTC

U.S. Core Producer Prices Expected to Rise 0.3% in August Amid Geopolitical Tensions and Inflation Concerns

7 sept 2026, 23:01 UTC

U.S. Producer Price Inflation (PPI) MoM for August set to release on September 10, with a forecasted rise of 0.4% amid inflation concerns and potential Fed interest rate hikes due to geopolitical tensions affecting oil prices.

7 sept 2026, 23:01 UTC

NZD/JPY is lower today amid broader market volatility and geopolitical tensions following U.S. military actions against Iranian tankers. The pair remains near its one-month low.

7 sept 2026, 23:01 UTC

Correlated Moves

AUD/JPY is trading lower, continuing a decline since Friday's close amid geopolitical tensions affecting investor sentiment and energy supply concerns.

7 sept 2026, 23:01 UTC

Correlated Moves

GBP/JPY is declining amid heightened market volatility from geopolitical tensions and U.S. military actions, continuing lower since Friday's close.

7 sept 2026, 23:01 UTC

Correlated Moves

CAD/JPY is declining, continuing a downward trend since Friday's close, influenced by geopolitical tensions and market volatility. The pair trades below its 20-day moving average.

7 sept 2026, 23:01 UTC

Macro News

The USD/JPY currency pair is trading lower as the yen strengthens amid global economic uncertainties and tensions in the Middle East.

7 sept 2026, 23:01 UTC

Correlated Moves

The EUR/JPY is lower today amid rising geopolitical tensions and a drop in USD/JPY. The exchange rate remains below its 20-day moving average.

7 sept 2026, 23:01 UTC

Correlated Moves

CHF/JPY is trading lower as geopolitical tensions influence market sentiment, following a notable decline earlier in the session. The pair remains below its 20-day moving average.

7 sept 2026, 22:51 UTC

Markets Anticipate ECB Deposit Facility Rate Hike Amid Rising Inflation and Geopolitical Tensions Ahead of September 10 Meeting.

7 sept 2026, 22:21 UTC

India's Inflation Rate Release on September 14, 2026, Sparks Caution Amid Geopolitical Tensions and Rising Costs.

7 sept 2026, 22:11 UTC

Mexico's Inflation Rate YoY for August 2026 set to release on September 9, with a forecast of 3.30% amid rising global oil prices and geopolitical tensions.

7 sept 2026, 22:11 UTC

Mexico's Inflation Rate Expected to Rise 0.25% in August Amid Global Economic Pressures and U.S. Interest Rate Concerns.

7 sept 2026, 22:01 UTC

MBA 30-Year Mortgage Rate Release on September 9, Amid Rising Rates and Anticipated Fed Hikes Influenced by Inflation Concerns.

7 sept 2026, 21:51 UTC

Brazil's Central Bank to Announce Interest Rate Decision Amid Global Economic Uncertainty on September 8, 2026.

Comparación entre iguales

Cambio de precio

Erasca Inc previsión

Precio Objetivo

By TipRanks

49.04% repunte

Estimación a 12 Meses

Media 24.13 USD 49.04%

Máximo 33 USD

Mínimo 20 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Erasca Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

8 ratings

Comprar

Mantener

Vender

De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Erasca Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.